1 unchanged sentence
Rule 10b5-1 and Non-Rule 10b5-1 Trading Arrangements
−Removed: During the three months ended September 30, 2024, neither the Company or any of its officers (as that term is defined by the SEC in Rule 16a-1(f) under the Exchange Act) or directors adopted or terminated a Rule 10b5-1 trading arrangement or a non Rule 10b5-1 trading arrangement for the sale of the Company’s common stock .
+Added: O n February 12, 2025 , Deborah Charych , a member of the Company's Board of Directors , adopted a Rule 10b5-1 trading plan.
+Added: Charych's Rule 10b5-1 trading plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) and provides for the potential sale of up to 58,917 shares of the Company’s common stock subject to stock options held by Dr.
+Added: Charych upon exercise of such stock options until December 31, 2025 .
+Added: On March 28, 2025 , Punit Dhillon , the Company’s Chief Executive officer and a member of the Company's Board of Directors , adopted a Rule 10b5-1 trading plan.
+Added: Dhillon's Rule 10b5-1 trading plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) and provides for (i) the potential sale of up to 68,846 shares of the Company’s common stock subject to restricted stock units held by Mr.
+Added: Dhillon until December 31, 2025 , which amount includes the sale of an indeterminate number of shares of the Company's common stock at market prices sufficient to cover Mr.
+Added: Dhillon's tax liability upon the vesting of such restricted stock units (ii) the potential sale of up to 25,000 shares of the Company’s common stock subject to restricted stock units held by Mr.
+Added: Dhillon until December 31, 2026 , which amount includes of the sale of an indeterminate number of shares of the Company's common stock at market prices sufficient to cover Mr.
+Added: Dhillon's tax liability upon the vesting of such restricted stock units, (iii) the potential sale of up to 20,322 shares of the Company’s common stock held by Mr.
+Added: Dhillon until December 31, 2025 and (iv) the potential sale of up to 50,000 shares of the Company’s common stock held by Mr.
+Added: Dhillon until December 31, 2026 .
3.1 Amended and Restated Articles of Incorporation of Registrant (incorporated by reference to Exhibit 3.1 to the Registrant's Annual Report on Form 10-K for the year ended December 31, 2023 filed with the SEC on March 22, 2024)
3.2 Amended and Restated Bylaws of Registrant (incorporated by reference to Exhibit 3.2 to our Annual Report on Form 10-K for the year ended December 31, 2020 filed on March 2, 2021)
−Removed: Skye Bioscience, Inc.
−Removed: Amended and Restated Omnibus Incentive Plan
−Removed: E mployment Agreement between the R egistrant and Dr.
−Removed: Puneet Arora (incorporated by ref ere nce to Exhib it 10.1 to the Re gistrant's Current Report on Form 8-K filed with the SEC on September 4, 2024)
31.1* Certification of Principal Executive Officer, pursuant to Rule 13a-14 and 15d-14 of the Securities Exchange Act of 1934
5 unchanged sentences
101 The following materials from the Skye Biosciences, Inc.
−Removed: Quarterly Report on Form 10-Q for the quarter ended September 30, 2024, formatted in Inline Extensible Business Reporting Language (iXBRL):
+Added: Quarterly Report on Form 10-Q for the quarter ended March 31, 2025, formatted in Inline Extensible Business Reporting Language (iXBRL):
(i) Condensed Consolidated Balance Sheets (Unaudited), (ii) Condensed Consolidated Statements of Operations (Unaudited), (iii) Condensed Consolidated Statements of Cash Flows (Unaudited), (iv) Condensed Consolidated Statements of Stockholders’ Deficit (Unaudited), and (v) related Notes to the Unaudited Condensed Consolidated Financial Statements.
6 unchanged sentences
a Nevada corporation
−Removed: November 7, 2024 By:
+Added: May 8, 2025 By:
/s/ Punit Dhillon
2 unchanged sentences
(Principal Executive Officer)
−Removed: November 7, 2024 By:
+Added: May 8, 2025 By:
/s/ Kaitlyn Arsenault
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.